// App-Quantinova.ai

3224 : Blocking FSTL1 reprograms cancer-caused abnormal immunity

Researchers

Presenter

  • Chie Kudo-Saito

Principal Investigators

  • Masayoshi Toyoura

  • Yuji Shoya

  • Akiko Ishida

  • Ryoko Kon

Medical Centers

  • National Cancer Center Hospital, Tokyo, Japan

  • Pharma Foods International Co., Ltd, Kyoto, Japan.

Locations

  • Japan

Companies

  • Pharma Foods Interna

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Mesenchymal stem cells

  • Solute Carrier Family 22 Member 3

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved